[1] World Health Organization. Consolidated guidelines on HIV prevention,diagnosis,treatment and care for key populations-2016Update[M]. Geneva:World Health Organization,2016.
|
[2] CLAUSEN LN. Factors associated with resolution and progression of HIV/hepatitis C virus infection[J]. Dan Med J,2014,61(4):B4838.
|
[3] CECEARELLI G,DETTORRE G,MANCONE M,et al. Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV/HCV coinfection:Case report and review of the literature[J]. Cardiovasc Revasc Med,2011,12(4):262-265.
|
[4] YOO TW,DONFIELD S,LAIL A,et al. Effect of hepatitis C virus(HCV)genotype on HCV and HIV-1 disease[J]. J Infect Dis,2005,191(1):4-10.
|
[5] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for hepatitis C(2019 version)[J]. J Clin Hepatol,2019,35(12):2670-2686.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2019年版)[J].临床肝胆病杂志,2019,35(12):2670-2686.
|
[6] Aids and Hepatitis C Professional Group,Society of Infectious Diseases,Chinese Medical Association,Chinese Center for Disease Control and Prevention. Chinese guidelines for diagnosis and treatment of HIV/AIDS(2018)[J]. Chin J Intern Med,2018,57(12):867-884.(in Chinese)中华医学会感染病分会艾滋病丙型肝炎学组,中国疾病预防控制中心.中国艾滋病诊疗指南(2018版)[J].中华内科杂志,2018,57(12):867-884.
|
[7] WANG M,YANG XL,ZHANG L,et al. Distribution characteristics of hepatitis C virus genotypes in Guizhou,China[J]. J Clin Hepatol,2020,36(2):309-313.(in Chinese)王梅,杨兴林,张流,等.贵州地区HCV感染者基因型分布特征[J].临床肝胆病杂志,2020,36(2):309-313.
|
[8] LI GY,SUN YM,LIU GW. Analysis on risk factors of HIV and HCV infections among drug users in Beijing in 2018[J]. Int J Virol,2019,26(6):387-391.(in Chinese)李桂英,孙燕鸣,刘国武.北京市吸毒人群感染HIV和丙型肝炎病毒危险因素分析[J].国际病毒学杂志,2019,26(6):387-391.
|
[9] HERNANDEZ MD,SHERMAN KE. HIV/hepatitis C coinfection natural history and disease progression[J]. Curr Opin HIV AIDS,2011,6(6):478-482.
|
[10] PLATT L,EASTERBROOK P,GOWER E,et al. Prevalence and burden of HCV co-infection in people living with HIV:A global systematic review and meta-analysis[J]. Lancet Infect Dis,2016,16(7):797-808.
|
[11] ZHANG F,ZHU H,WU Y,et al. HIV,hepatitis B virus,and hepatitis C virus coinfection in patients in the China National Free Antiretroviral Treatment Program,2010-12:aretrospective observational cohort study[J]. Lancet Infect Dis,2014,14(11):1065-1072.
|
[12] JIN ZY,LIU X,DING YY,et al. Cancer risk factors among people living with HIV/AIDS in China:A systematic review and meta-analysis[J]. Sci Rep,2017,7(1):4890.
|
[13] MARTINELLO M,AMIN J,MATTHEWS GV,et al. Prevalence and disease burden of hcv coinfection in hiv cohorts in the Asia Pacific Region:A systematic review and meta-analysis[J].AIDS Rev,2016,18(2):68-80.
|
[14] XIE NH,WANG X,WU S,et al. Epidemiological characteristics and influencing factors of HBV and HCV coinfections among patients with HIV/AIDS in Wuhan city[J]. Acta Med Univ Sci Technol Huazhong,2019,18(2):183-188.(in Chinese)谢年华,王夏,吴斯,等.武汉市HIV/AIDS合并HBV/HCV感染的流行特征和影响因素分析[J].华中科技大学学报(医学版),2019,18(2):183-188.
|
[15] CHEN HX,WANG H,LEI YH,et al. Advances in genotyping and molecular epidemiology of hepatitis C virus[J]. Int J Virol,2019,26(5):348-351.(in Chinese)陈红霞,王海,类延花,等.丙型肝炎病毒基因分型及其分子流行病学研究进展[J].国际病毒学杂志,2019,26(5):348-351.
|
[16] MESSINA JP,HUMPHREYS I,FLAXMAN A,et al. Global distribution and prevalence of hepatitis C virus genotypes[J].Hepatology,2015,61(1):77-87.
|
[17] SALEMOVIC D,PESIC-PAVLOVIC I,JEVTOVIC D,et al. Intravenous drug use-an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients[J]. Arch Med Sci,2017,13(3):652-658.
|
[18] CHEN W,LIAO B,HU F,et al. Changing epidemiology of hepatitis C virus genotype among patients with human immunodeficiency virus/hepatitis C virus coinfection in China[J].PLo S One,2016,11(9):e0161844.
|
[19] WANG YK,CHEN XC,WANG JB,et al. Molecular transmission clusters on HCV genotypes among newly reported HIV/HCV co-infection in Dehong Dai and Jingpo autonomous prefecture of Yunnan province,2016[J]. Chin J Epidemiol,2019,40(2):191-195.(in Chinese)王译葵,陈晓晨,王继宝,等.德宏傣族景颇族自治州2016年HIV/HCV合并感染者HCV分子传播簇分析[J].中华流行病学杂志,2019,40(2):191-195.
|
[20] DENG HH,LI XQ,GAO HB,et al. Comparison of HCV genotypes in patients with HIV/HCV co-infection and HCV monoinfection in GuangZhou[J]. J Prac Hepatol,2019,22(5):656-659.(in Chinese)邓浩辉,李晓强,高洪波,等.HIV/HCV混合感染者与HCV感染者感染HCV基因型分析[J].实用肝脏病杂志,2019,22(5):656-659.
|
[21] JI YJ,ZHAO M,SUN YL,et al. Observe the pathological changes of liver tissues in patients infected with hepatitis C virus and human immunodeficiency virus[J]. Chin J Intern Med,2006,45(11):939-941.(in Chinese)吉英杰,赵敏,孙艳玲,等.丙型肝炎病毒和人类免疫缺陷病毒合并感染者肝组织病理学观察[J].中华内科杂志,2006,45(11):939-941.
|
[22] ZHANG X,XU J,PENG H,et al. HCV coinfection associated with slower disease progression in HIV-infected former plasma donors nave to ART[J]. PLo S One,2008,3(12):e3992.
|
[23] LIU JH,ZHAO Y,SUN HQ,et al. Effect of HCV on disease progression in patients with HIV/HCV coinfection[J]. J Clin Hepatol,2014,30(6):501-504.(in Chinese)刘金花,赵艳,孙焕芹,等.HCV对HIV/HCV共感染患者病情进展的影响[J].临床肝胆病杂志,2014,30(6):501-504.
|
[24] HERNANDEZ MD,SHERMAN KE. HIV/hepatitis C coinfection natural history and disease progression[J]. Curr Opin HIV AIDS,2011,6(6):478-482.
|
[25] KIRK GD,MEHTA SH,ASTEMBORSKI J,et al. HIV,age,and the severity of hepatitis C virus-related liver disease:A cohort study[J]. Ann Intern Med,2013,158(9):658-666.
|
[26] AMOLD DM,JULIAN JA,WALKER IR,et al. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up[J]. Blood,2006,108(2):460-464.
|
[27] MASTROIANNI CM,LICHTNER M,MASCIA C,et al. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection[J]. Int J Mol Sci,2014,15(6):9184-9208.
|
[28] ERQOU S,MOHANTY A,MURTAZA KASI P,et al. Predictors of mortality among United States veterans with human immunodeficiency virus and hepatitis C virus coinfection[J]. ISRN Gastroenterol,2014,2014:764540.
|
[29] RABOUD J,ANEMA A,SU D,et al. Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy[J]. HIV Clin Trials,2012,13(2):90-102.
|
[30] REICHE EM,BONAMETTI AM,MORIMOTO HK,et al. Epidemiological,immunological and virological characteristics,and disease progression of HIV-1/HCV co-infected patients from a southern Brazilian population[J]. Int J Mol Med,2008,21(3):387-395.
|
[31] SENGUPTA S,POWELL E,KONG L,et al. Effects of HCV on basal and tat-induced HIV LTR activation[J]. PLo S One,2013,8(6):e64956.
|
[32] LI CX,LIU J,GUAN W,et al. Analysis of the influential factors on treatment effect of direct-acting antiviral agents in patients with HIV/HCV co-infection[J]. J Kunming Med Univ,2019,40(8):102-106.(in Chinese)李重熙,刘俊,关玮,等.DAAs对HIV合并丙型肝炎治疗效果的影响因素[J].昆明医科大学学报,2019,40(8):102-106.
|
[1] | Committee on HIV/Liver Diseases, Chinese Association of STD and AIDS Prevention and Control; Guangzhou Eighth People’s Hospital, Guangzhou Medical University. Chinese expert consensus on the diagnosis and treatment of HIV co-infection with HBV and HCV[J]. Journal of Clinical Hepatology, 2024, 40(6): 1107-1113. doi: 10.12449/JCH240607 |
[2] | Li LIU, Lixian CHANG, Zhiyong CHEN, Junyi LI, Chunyun LIU. Efficacy and safety of sofosbuvir/velpatasvir alone or in combination with ribavirin in treatment of patients with genotype 3B HCV/HIV infection[J]. Journal of Clinical Hepatology, 2024, 40(2): 271-277. doi: 10.12449/JCH240209 |
[3] | Jiajun LU, Fazhu FEI, Bin REN. Research advances in nonalcoholic fatty liver disease in individuals with HIV infection[J]. Journal of Clinical Hepatology, 2023, 39(6): 1446-1453. doi: 10.3969/j.issn.1001-5256.2023.06.030 |
[4] | Haohui DENG, Shuifeng LI, Qianchang FENG, Linghua LI. Naturally occurring resistance-associated variants to NS3/4A protease and NS5A inhibitors in patients with HIV/HCV co-infection or HCV infection alone[J]. Journal of Clinical Hepatology, 2022, 38(2): 328-333. doi: 10.3969/j.issn.1001-5256.2022.02.015 |
[5] | Qiu Chen, Jia ShengNan, Zhang Qian, Zhang ChuanHui, Jin ZhenJing, Yang LanLan. Patients with mixed genotype hepatitis C virus infection treated by sofosbuvir/velpatasvir/ribavirin: A case report[J]. Journal of Clinical Hepatology, 2020, 36(7): 1591-1592. doi: 10.3969/j.issn.1001-5256.2020.07.028 |
[6] | Wang Mei, Yang XingLin, Zhang Liu, Wang Jun, Wang Yi. Distribution characteristics of hepatitis C virus genotypes in Guizhou,China[J]. Journal of Clinical Hepatology, 2020, 36(2): 309-313. doi: 10.3969/j.issn.1001-5256.2020.02.015 |
[7] | Yang XiuMei, Halimulati Abdusalamu, Ji Dong, Wang ChunYan, Chen SongHai, Fu YiMing, Yang WuCai, Li ZhongBin. Efficiency of transient elastography in diagnosis of liver fibrosis in patients with HIV/HCV co-infection[J]. Journal of Clinical Hepatology, 2020, 36(8): 1732-1736. doi: 10.3969/j.issn.1001-5256.2020.08.011 |
[8] | Chen Xu, Su MingHua, Jiang JianNing, Liu ZhiHong, Wei Qi, Wu FeiFei, Zhou Yi, Teng ChunLing. Epidemiological features of positive anti-HCV among the HIV-infected population in Guangxi,China[J]. Journal of Clinical Hepatology, 2020, 36(1): 88-93. doi: 10.3969/j.issn.1001-5256.2020.01.020 |
[9] | Li Peng, Ding HuiGuo. Committee on gynecologic practice of the American College of Obstetricians and Gynecologists:hepatitis B, hepatitis C, and human immunodeficiency virus infections in obstetrician-gynecologists[J]. Journal of Clinical Hepatology, 2016, 32(7): 1250-1252. doi: 10.3969/j.issn.1001-5256.2016.07.004 |
[10] | Chen ChiChi, Chen XiaoRong, Lu YunFei. A case of acute fulminant hepatitis B with HIV infection[J]. Journal of Clinical Hepatology, 2016, 32(9): 1787-1788. doi: 10.3969/j.issn.1001-5256.2016.09.033 |
[11] | Luo Shan, Chen Fei, Zhang Jian, Wu ZhiHui, Ou WenSheng, Huang Jian, Wen Bo, Ju XiaoWang. Hepatitis C virus infection and genotype distribution among injecting drug users in methadone clinics in Chenzhou, China[J]. Journal of Clinical Hepatology, 2015, 31(11): 1841-1844. doi: 10.3969/j.issn.1001-5256.2015.11.017 |
[12] | Wu ZhiFeng, Zhang GuangWen, Yang Xuan. Influence of concurrent HIV infection on antiviral therapy in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2015, 31(11): 1837-1840. doi: 10.3969/j.issn.1001-5256.2015.11.016 |
[13] | Peng MiLin, Xiao XinQiang, Jiang YongFang, Tian Yi, Xu Yun, Zhang Min, Wang WenLong, Peng Feng, Gong GuoZhong. Preliminary study on effect of hepatitis C virus nonstructural protein 5A on HIV LTR[J]. Journal of Clinical Hepatology, 2014, 30(2): 136-140. doi: 10.3969/j.issn.1001-5256.2014.02.010 |
[14] | Liu JinHua, Zhao Yan, Sun HuanQin, Liu Ning, Qiao GuiFang, Wang ZiKang, Xu Jie, Li Ang, Zhang YongHong. Effect of HCV on disease progression in patients with HIV /HCV coinfection[J]. Journal of Clinical Hepatology, 2014, 30(6): 501-504. doi: 10.3969/j.issn.1001-5256.2014.06.006 |
[15] | Gu Bin, Huang HuiQin, Hou XiaoLan, Ning Feng, Zhang Yan, Li Lu. Relationship between hepatitis C virus genotypes and viral load in Chenzhou, China[J]. Journal of Clinical Hepatology, 2013, 29(11): 832-834. doi: 10.3969/j.issn.1001-5256.2013.11.008 |
[16] | Sun HongQing, Huang Qin, Shen Fang, Wu Min, Zhou XiaoMing, Cai WeiPing, Hu YunWen. Effects of different anti- HIV therapies on progression of hepatitis C in HCV / HIV- coinfected patients[J]. Journal of Clinical Hepatology, 2013, 29(11): 835-838. doi: 10.3969/j.issn.1001-5256.2013.11.009 |
[17] | Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64. |
[18] | Kang WenZhen, Huang DeDong, Li Yuan, Zhuang Yan, Zhai Song, Zhao Ke, Xie YuMei, Sun YongTao. HIV-specific cytotoxic T-lymphocyte responses in patients co-infected with HIV and HCV[J]. Journal of Clinical Hepatology, 2011, 27(1): 68-71+80. |
[19] | Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294. |
[20] | Jiao Jian, Wang JiangBin. Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV[J]. Journal of Clinical Hepatology, 2004, 20(2): 75-76. |